Abstract:CMR techniques are increasingly being used to evaluate myocardial extracellular volume (ECV). In the most commonly applied method, ECV is quantified using haematocrit-adjusted myocardial and blood T1 values measured before and after gadolinium bolus. The technique is based on a two-compartment model, which assumes contrast kinetic effects to be negligible due to a dynamic equilibrium between blood and myocardium (Dynamic-Equilibrium CMR; DynEq-CMR). This study assessed the effect of contrast dose, post-contrast acquisition time, myocardial regionality, cardiac cycle and gender on DynEq-CMR ECV measurement. 30 healthy volunteers (asymptomatic, no cardiovascular risk factors, normal examination and ECG) were prospectively split into 3 age and sex-matched groups (there were also no differences in mean eGFR, body surface area, heart rate, LV mass and volumetrics between groups): Group A received 0.10 mmol/kg Gd-DTPA, Group B 0.15 mmol/kg and Group C 0.20 mmol/kg. Mid-ventricular short-axis modified look locker inversion recovery (MOLLI) imaging was performed at 1.5T before, and at 2 min intervals between 2–20 min after, contrast administration, with same-day haematocrit measurement. MOLLI imaging was repeated in early systole (150 ms after R wave) pre- and at 10 min post-contrast. Resulting pixelwise T1 maps (figure 1; T1 maps at selected time-points are shown) were used to calculate ECV (Matlab). (Phantom studies performed prior to patient scanning determined T1 measurement accuracy and heart-rate correction algorithm). Figure 1 Pre-contrast myocardial (A 1051±49 ms; B 1045±49 ms; C 1040±43 ms; p=0.87) and blood (A 1678±98 ms; B 1645±118 ms; C 1686±101 ms; p=0.66) T1 times did not differ significantly between groups. Mean myocardial (A 542±65 ms; B 465±69 ms; C 407±55 ms; p<0.001) and blood (A 407±73 ms; B 307±67 ms; C 252±48 ms; p<0.001) T1 averaged over all time points post-contrast shortened significantly as contrast dose increased (figure 2). Mean ECV was significantly higher in group A compared to groups B and C (A 27.7±3.7%; B 25.8±3.4%; C 25.8±2.8%; p<0.001). The difference between groups B and C was not significant. ECV increased linearly over time in each group; between 2 and 20 min post-contrast, ECV increased from 27.2±2.7% to 28.8±3.4%, p=0.020 in group A; 25.3±2.8% to 26.5±3.2%, p=0.004 in group B; and 25.2±1.7% to 26.2±2.1%, p=0.068 in group C. ECV varied significantly between myocardial regions, being highest in the septum and lowest in the lateral wall in each group. ECV did not differ significantly between diastole and systole. ECV was significantly higher in females in each group (A female 29.6±3.0%, male 25.4±3.0%, p<0.001; B female 27.4±2.7%, male 23.6±2.9%, p<0.001; C female 26.1±2.8%, male 24.7±2.5%, p=0.027). Figure 2 The small increase in ECV over time suggests that an incomplete dynamic equilibrium between blood and myocardium is achieved. DynEq-CMR-derived ECV varies according to contrast dose, myocardial region and gender.

Left Ventricular Myocardial T1 Values and Extracellular Volume Fraction in Asymptomatic Subjects: Variations According to Left Ventricular Segments and Correlation with Cardiovascular Risk Factors

T1 values and extracellular volume fraction in asymptomatic subjects: variations in left ventricular segments and correlation with cardiovascular risk factors

Abstract 13954: Myocardial T1 Mapping at 3 T: Reference Values and Influencing Factors

Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy

Left ventricular myocardial tissue characteristics and function among healthy subjects with varying atherosclerotic cardiovascular disease risk

Hypertrophic Cardiomyopathy and Left Ventricular Hypertrophy in Hypertensive Heart Disease with Mildly Reduced or Preserved Ejection Fraction: Insight from Altered Mechanics and Native T1 Mapping.

Abstract 15164: the Different Prognostic Values of T1 Mapping in Patients with Hypertrophic Cardiomyopathy

Phantom-based correction for standardization of myocardial native T1 and extracellular volume fraction in healthy subjects at 3-Tesla cardiac magnetic resonance imaging

Myocardial extracellular volume fraction quantification based on T1 mapping at 3 T: quality optimization by contour-based registration and segmental analysis

T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy

Age and Gender Impact the Measurement of Myocardial Interstitial Fibrosis in a Healthy Adult Chinese Population: A Cardiac Magnetic Resonance Study.

Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison with Two Guidelines.

The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy

Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy

084 EFFECT OF CONTRAST DOSE, POST-CONTRAST ACQUISITION TIME, MYOCARDIAL REGIONALITY, CARDIAC CYCLE AND GENDER ON DYNAMIC-EQUILIBRIUM CONTRAST CMR MEASUREMENT OF MYOCARDIAL EXTRACELLULAR VOLUME

Associate variables of coronary computed tomographic angiography-derived extracellular volume fraction and cardiac magnetic resonance-derived late-gadolinium enhancement

Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases

Myocardial Extracellular Volume Assessed by Cardiovascular Magnetic Resonance May Predict Adverse Left Ventricular Remodeling in Rheumatic Heart Disease after Valvular Surgery.

Basal inferior-septal segment is highly susceptible to deformation in the clinical spectrum of transthyretin-derived cardiomyopathy

Reference Values of Myocardial T1 Relaxation Times in Healthy Latin American Patients

Segmental myocardial tissue remodeling and atrial arrhythmias in hypertrophic cardiomyopathy: Findings from T1-mapping MRI